The gut microbiome

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 4, 2014, Pages 217-223

  Actis, Giovanni C ^a  

^a Multidisciplinary Private Practice Office   (Italy)

Author keywords

Gut flora; Gut microbiome; Inflammasomes; Inflammatory bowel disease; Pathogen associated molecular patterns

Indexed keywords

ANTIBIOTIC AGENT; INFLAMMASOME; SHORT CHAIN FATTY ACID; PROBIOTIC AGENT;

ARTHRITIS; ARTICLE; CAMPYLOBACTER CONCISUS; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE INFECTION; DIET; DRUG USE; DYSBIOSIS; ESCHERICHIA COLI; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LIFESTYLE; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVOTELLA; PREVOTELLA COPRI; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW (TOPIC); ANIMAL; DRUG EFFECTS; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; INTESTINE MUCOSA; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; DIET; ESCHERICHIA COLI; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MICROBIOTA; OBESITY; PROBIOTICS;

EID: 84922954114     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528113666140623113221     Document Type: Article

References (59)

1. Scher, J.U.; Abramson, S.B. The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol., 2011, 7(10), 569-578.
2. Schreiber, S.; Rosenstiel, P.; Albrecht, M.; Hampe, J.; Krawczak M. Genetics of Crohn’s disease, an archetypal inflammatory barrier disease. Nat. Rev. Genet, 2005, 6(5), 376-388.
3. Seksik, P. Gut microbiota and IBD. Gastroenterol. Clin. Biol., 2010, 34 (Suppl 1), S44-51.
4. Rosenstiel, P. Stories of love and hate: innate immunity and hostmicrobe cross-talk in the intestine. Curr. Opin. Gastroenterol., 2013, 29(2), 125-132.
5. Shaw, S.Y.; Blanchard, J.F.; Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol., 2010, 105(12), 2687-2692.
6. Adlerberth, I.; Wold, A.E. Establishment of the gut microbiota in western infants. Acta. Paediatr., 2009, 98(2), 229-238.
7. Dominguez-Bello, M.G.; Costello, E.K.; Contreras, M.; Magris, M.; Hidalgo, G.; Fierer, N.; Knight, R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U S A, 2010, 107(26), 11971-11975.
8. Turroni, F.; Peano, C.; Pass, D.A.; Foroni, E.; Severgnini, M.; Claesson, M.J.; Kerr, C.; Hourihane, J.; Murray, D.; Fuligni, F.; Gueimonde, M.; Margolles, A.; De Bellis, G.; O’Toole, P.W.; van Sinderen, D.; Marchesi, J.R.; Ventura, M. Diversity of bifidobacteria within the infant gut microbiota. PLoS One, 2012, 7(5), e36957.
9. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; Heath, A.C.; Warner, B.; Reeder, J.; Kuczynski, J.; Caporaso, J.G.; Lozupone, C.A.; Lauber, C.; Clemente, J.C.; Knights, D.; Knight, R.; Gordon, J.I. Human gut microbiome viewed across age and geography. Nature, 2012, 486(7402), 222-227.
10. Ramakrishna, B.S. Role of the gut microbiota in human nutrition and metabolism. J. Gastroenterol. Hepatol., 2013, 28 (Suppl 4), 9-17.
11. Probert, H.M.; Apajalahti, J.H.; Rautonen, N.; Stowell, J.; Gibson, G.R. Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl. Environ. Microbiol., 2004, 70(8), 4505-4511.
12. Ridlon, J.M.; Kang, D.J.; Hylemon, P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res., 2006, 47(2), 241-259.
13. Dawson, P.A.; Lan, T.; Rao, A. Bile acid transporters. J. Lipid Res., 2009, 50(12), 2340-2357.
14. Lord, R.S.; Bralley, J.A. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern. Med. Rev., 2008, 13(4), 292-306.
15. Serino, M.; Luche, E.; Gres, S.; Baylac, A.; Bergé, M.; Cenac, C.; Waget, A.; Klopp, P.; Iacovoni, J.; Klopp, C.; Mariette, J.; Bouchez, O.; Lluch, J.; Ouarné, F.; Monsan, P.; Valet, P.; Roques, C.; Amar, J.; Bouloumié, A.; Théodorou, V.; Burcelin, R. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut, 2012, 61(4), 543-553.
16. Actis, G.C.; Pellicano, R.; Rosina, F. Antibiotics and NSAIDS in outpatient practice: indications and unwanted effects in a gastroenterological setting. Curr. Drug Saf., 2014, [E-pub ahead of print].
17. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. PNAS (USA) 2010, 107 (33), 14691-14696.
18. Maslowski, K.M.; Mackay, C. R. Diet, gut microbiota and immune responses. Nat. Immunol., 2011, 12(1), 5-9.
19. Moreno-Indias, I.; Cardona, F.; Tinahones, F.J.; Queipo-Ortuño, M. I. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol., 2014, 5, 190.
20. Ley, R.E.; Bäckhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U S A, 2005, 102(31), 11070-11075.
21. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature, 2006, 444(7122), 1022-1023.
22. Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S. Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges. Int. J. Mol. Sci., 2014, 15(3), 4158-4188.
23. Kalliomäki, M.; Collado, M.C.; Salminen, S.; Isolauri, E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr., 2008, 87(3), 534-538.
24. Pickup, J.C.; Crook, M.A. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia, 1998, 41(10), 1241- 1248.
25. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature, 2006, 444(7121), 860-867.
26. Shoelson, S.E.; Lee, J.; Goldfine, A. B. Inflammation and insulin resistance. J. Clin. Invest., 2006, 116(7), 1793-1801.
27. Andoh, A.; Imaeda, H.; Aomatsu, T.; Inatomi, O.; Bamba, S.; Sasaki, M.; Saito, Y.; Tsujikawa, T.; Fujiyama, Y. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis. J. Gastroenterol., 2011, 46(4), 479-486.
28. Martinez, C.; Antolin, M.; Santos, J.; Torrejon, A.; Casellas, F.; Borruel, N.; Guarner, F.; Malagelada, J.R. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am. J. Gastroenterol., 2008, 103(3), 643-648.
29. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; Biddinger, S.B.; Dutton, R.J.; Turnbaugh, P.J. Diet rapidly and reproducibly alters the human gut microbiome. Nature, 2014, 505, 559-563.
30. Leone, V.; Chang, E.B.; Devkota, S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel disease. J. Gastroenterol., 2013, 48, 315-321.
31. Darfeuille-Michaud, A.; Neut, C.; Barnich, N.; Lederman, E.; Di Martino, P.; Desreumaux, P.; Gambiez, L.; Joly, B.; Cortot, A.; Colombel, J.F. Presence of adherent E. coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology, 1998, 115(6), 1405-1413.
32. Barnich, N.; Carvalho, F.A.; Glasser, A.L.; Darcha, C.; Jantscheff, P.; Allez, M.; Peeters, H.; Bommelaer, G.; Desreumaux, P.; Colombel, J.F.; Darfeuille-Michaud, A. CEACAM6 acts as a receptor for adherent -invasive E. Coli, supporting ileal mucosa colonization in Crohn’s disease. J. Clin. Invest., 2007, 117(6), 1566-1574.
33. Darfeuille-Michaud, A.; Boudeau, J.; Bulois, P.; Neut, C.; Glasser, A.L.; Barnich, N.; Bringer, M.A.; Swidsinski, A.; Beaugerie, L.; Colombel, J.F. High prevalence of adherent -invasive E. Coli associated with ileal mucosa in Crohn’s disease. Gastroenterology, 2004, 127(2), 412-421.
34. Selby, W.; Pavli, P.; Crotty, B.; Florin, T.; Radford-Smith, G.; Gibson, P.; Mitchell, B.; Connell, W.; Read, R.; Merrett, M.; Ee, H.; Hetzel, D. Antibiotics in Crohn’s disease Study Group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology, 2007, 132(7), 2313-2319.
35. Mukhopadhya, I.; Thomson, J.M.; Hansen, R. Detection of Campylobacter Concisus in colonic biopsies from adult patients with UC. Gut, 2011, 60, A211.
36. Zhang, L.; Lee, H.; Grimm, M.C.; Riordan, S.M.; Day, A.S.; Lemberg, D.A. Campylobacter Concisus and inflammatory bowel disease. World J. Gastroenterol., 2014, 20(5), 1259-1267.
37. Mahendran, V.; Tan, Y.S.; Riordan, S.M.; Grimm, M.C.; Day, A.S.; Lemberg, D.A.; Octavia, S.; Lan, R.; Zhang, L. The prevalence and polymorphism of zonula occludens toxin gene in multiple Campylobacter Concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One, 2013, 8(9), e75525.
38. Kalischuk, L.D.; Buret, A.G. A role for Campylobacter Jejuni-induced enteritis in inflammatory bowel disease? Am. J. Physiol. Gastrointest. Liver Physiol., 2010, 298(1), G1-G9.
39. Ogrendik, M. Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens. Int. J. Gen. Med., 2013, 6, 383-386.
40. Scher, J.U.; Sczesnak, A.; Longman, R.S.; Segata, N.; Ubeda, C.; Bielski, C.; Rostron, C.; Cerundolo, V.; Pamer, E.G.; Abramson, S.B.; Huttenhower, C.; Littman, D.R. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. E-life, 2013, 2,e01202.
41. Mathis, D. A gut feeling about arthritis. E-life, 2013, 2,e01608.
42. Crumeyrolle-Arias, M.; Jaglin, M.; Bruneau, A.; Vancassel, S.; Cardona, A.; Daugé, V.; Naudon, L.; Rabot, S. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology, 2014, 42, 207-217.
43. Eisenbarth, S.C.; Flavell, R.A. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol. Med., 2009, 1(2), 92-98.
44. Vance, R.E.; Isberg, R.R.; Portnoy, D.A. Patterns of pathogenesis: discrimination of pathogenic and non-pathogenic microbes by the innate immune system. Cell Host Microbe., 2009, 6(1), 10-21
45. Arancibia, S.A.; Beltrán, C.J.; Aguirre, I.M.; Silva, P.; Peralta, A.L.; Malinarich, F.; Hermoso, M.A. Toll-like receptors are key participants in innate immune responses. Biol. Res., 2007, 40(2), 97-112.
46. Bogefors, J.; Kvarnhammar, A.M.; Latif, L.; Petterson, T.; Uddman, R.; Cardell, L.O. Retinoic acid-inducible gene 1-like receptors in the upper respiratory tract. Am. J. Rhinol. Allergy, 2011, 25(6), e262-e267.
47. Robertson, S.J.; Girardin, S.E. NOD-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both? Curr. Opin. Gastroenterol., 2013, 29(1), 15-22.
48. Martinon, F.; Burns, K.; Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell, 2002, 10(2), 417-426.
49. Schroder, K.; Tschopp, J. The inflammasomes. Cell, 2010, 140(6), 821-832.
50. Dos Santos, G.; Kutuzov, M.A.; Ridge, K.M. The inflammasomes in lung diseases. Am. J. Physiol., 2012, 303, L627-L633.
51. Elinav, E.; Strowig, T.; Henao-Mejia, J.; Flavell, R.A. Regulation of the antimicrobial response by NLR proteins. Immunity, 2011, 34(5), 665-679.
52. Van Ooij, C. Immunology: NLRP6 keeps the bad bacteria at bay. Nat. Rev. Microbiol., 2011, 9(7), 481.
53. Hao, L.Y.; Liu, X.; Franchi, L. Inflammasomes in inflammatory bowel disease pathogenesis. Curr. Opin. Gastroenterol., 2013, 29(4), 363-369.
54. Allegretti, J.R.; Hamilton, M.J. Restoring the gut microbiome for the treatment of inflammatory bowel disease. World J. Gastroenterol., 2014, 20(13), 3468-3474.
55. Bennett, J.D.; Brinkman, M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet, 1989, 1(8630), 164.
56. Borody, T.J.; George, L.; Andrews, P.; Brandl, S.; Noonan, S.; Cole, P.; Hyland, L.; Morgan, A.; Maysey, J.; Moore-Jones, D. Bowel flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med. J. Aust., 1989, 150(10), 604.
57. Anderson, J.L.; Edney, R.J.; Whelan, K. Systematic review: fecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol. Ther., 2012, 36(6), 503-516.
58. Brandt, L.J.; Aroniadis, O.C. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc., 2013, 78(2), 240-249.
59. Martinez-Montiel, MdelP.; Gómez-Gómez, G.J.; Flores, A.I. Therapy with stem cells in inflammatory bowel disease. World J. Gastroenterol., 2014, 20(5), 1211-1227.